Electrocardiographic left ventricular hypertrophy and arterial stiffness: the Ohasama study

Daisuke Watabe1, Junichiro Hashimoto, Rieko Hatanaka

  • 1Department of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Science and Medicine, Aoba, Aramaki, Sendai, Japan.

Insights

Arterial stiffness, measured by pulse wave velocity (PWV), is independently linked to left ventricular hypertrophy (LVH) in the general population, even after accounting for blood pressure. This finding highlights arterial stiffness as a significant risk factor for LVH.

Area of Science:

  • Cardiovascular Physiology
  • Clinical Cardiology
  • Biomedical Engineering

Background:

  • The independent contribution of arterial stiffness to left ventricular hypertrophy (LVH) beyond blood pressure (BP) remains unclear.
  • Investigating the relationship between pulse wave velocity (PWV) and LVH is crucial for understanding cardiovascular remodeling.

Purpose of the Study:

  • To determine if arterial stiffness, assessed by brachial-to-ankle pulse wave velocity (baPWV), is independently associated with LVH.
  • To explore the role of arterial stiffness as a risk factor for LVH in a large population cohort.

Main Methods:

  • Brachial-to-ankle pulse wave velocity (baPWV) measured in 798 individuals.
  • Left ventricular hypertrophy (LVH) diagnosed using electrocardiographic criteria (Cornell voltage-duration product or Sokolow-Lyon voltage).
  • Development of a theoretical baPWV nomogram for a healthy group to calculate a PWV index; multivariate analyses performed.

Main Results:

  • A predictive model for theoretical baPWV was established: baPWV = 0.20 x age + 0.13 x MAP + 0.05 x HR - 11.74 (R²=0.56).
  • The PWV index was significantly higher in individuals with LVH compared to those without (P=.025).
  • Increased baPWV was independently associated with LVH, along with Mean Arterial Pressure (MAP), and medications for hypertension and diabetes. A 1 SD increase in baPWV correlated with a 26% higher risk of LVH (P=.022).

Conclusions:

  • Arterial stiffness is an independent predictor of electrocardiographically determined LVH in the general population.
  • The prevalence of LVH increases linearly with the number of risk factors, including hypertension, diabetes, and elevated baPWV.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...